Huluwa Pharmaceutical Group Secures Two Honors at the 2026 West Lake Awards

On April 13, the 2026 Wuzhen Health Conference and the 5th OTC Conference, themed "Reconfiguration and Leap | Symphony of Tomorrow", officially opened in Wuzhen. At the highly anticipated West Lake Awards ceremony, Liu Jingping, Party Secretary and Chairperson of Huluwa Pharmaceutical Group, was awarded the title of "West Lake Award · Influential Figure in China's Pharmaceutical Industry" in recognition of her outstanding industry leadership and exceptional contributions to children's health. The Group's core product, Xiao'er Feire Kechuan Granules, received the "West Lake Award · Most Popular Star Product in Pharmacies" for its stringent quality control system and strong consumer reputation.

The conference brought together more than 10,000 representatives from government authorities, academicians of the Chinese Academy of Sciences and the Chinese Academy of Engineering, industry associations, pharmaceutical and healthcare enterprises, and media organizations. Participants jointly explored pathways for the industry's transformation from a "treatment-centered" model to a "people's health-centered" paradigm, and jointly outlined a development blueprint centered on "proactive health, family-based care, and industrial upgrading".

The "West Lake Award · Influential Figure in China's Pharmaceutical Industry" is intended to recognize industry leaders who have made outstanding contributions to the development of China's pharmaceutical sector. Liu Jingping's receipt of this award has received unanimous recognition within the industry. Under the leadership of Liu Jingping, Huluwa Pharmaceutical has long focused on the niche segment of children's health. Upholding its corporate mission of "Healthy Chinese Children", the company has remained committed to R&D innovation and industrial upgrading, continuously strengthening its portfolio of pediatric health products. Through forward-looking strategic planning, it has advanced its digital transformation, establishing end-to-end quality control from raw materials to finished products to ensure the safety and efficacy of every product. At the same time, the company has long been engaged in public education on the safe use of pediatric medicines, disseminating knowledge on scientific parenting and rational medication use through diversified channels, fully demonstrating the sense of responsibility of pharmaceutical entrepreneurs in the new era.

The "West Lake Award · Most Popular Star Product in Pharmacies" is determined through a comprehensive evaluation based on real sales data from hundreds of thousands of retail pharmacies nationwide, combined with consumer research. It represents dual recognition from both retail terminals and the consumer market. The award received by Huluwa Pharmaceutical Group's Xiao'er Feire Kechuan Granules is strong evidence of its market-leading position. With its outstanding clinical value, the product has become a commonly used pediatric medicine in countless households.

 Winning these two major awards is both a recognition of Huluwa Pharmaceutical Group's past achievements and a set of higher expectations for its future development. Liu Jingping stated: "This honor belongs to every member of the Huluwa team. We will take this as a new starting point, continue to increase investment in innovation and R&D, provide more high-quality health products for Chinese children, and contribute Huluwa's professional expertise to the implementation of the 'Healthy China' strategy."